More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...

The Government announces the official naming of Hong Kong's first Chinese medicine hospital as The Chinese Medicine Hospital ...

The answer is not yet known. Researchers continue to study how sleep might affect cancer risk. Some studies suggest that the risk of cancer may increase when there are chronic sleep problems. This ...

Institute of Herbal Medicine (IHM) has made a groundbreaking advancement in treating type 2 diabetes with the introduction of ...

A team of scientists led by Nanyang Technological University Singapore (NTU Singapore) and Hong Kong University (HKU) has ...

For young people living with diabetes in Quebec, adolescence and young adulthood are periods marked by a significantly higher ...

AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding to Vivance. The name, derived ...

What is perimenopause, exactly? We sat down with experts to learn more about this little-known transitional period in women's ...

VEGFR2 (vascular endothelial growth factor receptor 2) antagonist is an antineoplastic agent that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis ...

Expanding Capabilities to Support Early and Late-Stage Drug Development with Comprehensive Manufacturing SolutionsElkridge, Maryland--(Newsfile ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

The global healthcare regulatory affairs outsourcing market is experiencing a robust upward trajectory, with an estimated valuation of USD 1,985.60 million in 2023, projected to reach USD 4,052.30 ...